Gaingels
Phillip Madanire is an accomplished entrepreneur and investor with extensive experience in business consulting, venture capital, and advisory roles across various global markets. As the Founder of Stealth Civic and Social Organization since June 2025, Phillip also serves as a Managing Consultant at Acrius Strategy, specializing in business consulting and services since July 2018. Throughout a diverse career spanning over two decades, Phillip has held various advisory and consulting positions with multiple companies and startups, contributing to their successful exits. Notably, Phillip is an investor with Gaingels, Aavia, Axiom Space, Q Bio, Omnipulse Bio, OKOA Rescue, and Kabisa, focusing on innovative ventures in technology, health, and sustainability. Phillip's educational credentials include an MBA from Harvard Business School, a Master’s in Industrial and Product Design from the Rhode Island School of Design, and a Bachelor's in Architecture from the School of Planning and Architecture in New Delhi.
This person is not in any teams
This person is not in any offices
Gaingels
1 followers
Gaingels is the leading venture investment syndicate in service of the LGBT community and its allies. Through their 700+ individual members and family offices, they have invested over $50,000,000 into 120+ companies since 2016, with 80% of that since January 2019. Gaingels invests in companies with LGBT founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams. The Gaingels network actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments. Gaingels regularly co-invests with select VC leads across a variety of sectors, from technology to B2B, healthcare and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO.